Discover novel disease insights and enable Precision Medicine
Taxonomy3® identifies genetically-defined patient subgroups…

…and SNPs associated with disease risk in each of those sub-groups

Taxonomy3® is a novel in silico platform technology that utilises proprietary ground-breaking mathematical algorithms to perform complex multivariate analysis of genetic data.
Taxonomy3® is used to analyse complex genetic datasets to identify and characterise novel drug target candidates. Since these novel targets are based on human genetic data, the resulting drugs have a greater probability of successful clinical development and product realisation. By performing highly sensitive in silico mining and analysis of publicly available DNA databases, Taxonomy3® is able to identify previously unknown genetic linkages and interactions between genes and biological pathways in a broad range of diseases. This enables the discovery of targets that cause disease, rather than those that are simply associated with its symptoms, and thereby provides the best starting point for drug discovery, biomarker identification and patient stratification, and ultimately improving the chances of clinical success.
Compared to univariate approaches, which are standard in the field, the multivariate approach employed by Taxonomy3® provides greater sensitivity and therefore reveals more disease targets.
Methodology generating single peak
Methodology generating multiple peaks
This website uses 'cookies' to give you the best most relevant experience. To continue you have to agree to our use of cookies policy and how and why we use cookies.
You can change which cookies are set at any time and find out more about them by reading our privacy policy.